Terms: = Liver cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Staging
72 results:
1. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
2. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
3. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.
Risaliti M; Bartolini I; Campani C; Arena U; Xodo C; Adotti V; Rosi M; Taddei A; Muiesan P; Amedei A; Batignani G; Marra F
World J Gastroenterol; 2022 Aug; 28(29):3981-3993. PubMed ID: 36157535
[TBL] [Abstract] [Full Text] [Related]
5. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
[TBL] [Abstract] [Full Text] [Related]
6. C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Tada T; Kumada T; Hiraoka A; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Aoki T; Koizumi Y; Nakamura S; Joko K; Hiasa Y; Kudo M
Sci Rep; 2022 May; 12(1):8421. PubMed ID: 35589772
[TBL] [Abstract] [Full Text] [Related]
7. Adrenocortical cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract] [Full Text] [Related]
8. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract] [Full Text] [Related]
9. Equivalent tumor detection for early and late FAPI-46 PET acquisition.
Ferdinandus J; Kessler L; Hirmas N; Trajkovic-Arsic M; Hamacher R; Umutlu L; Nader M; Zarrad F; Weber M; Fendler WP
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3221-3227. PubMed ID: 33620560
[TBL] [Abstract] [Full Text] [Related]
10. liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic liver cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract] [Full Text] [Related]
11. Single source split filter dual energy: Image quality and liver lesion detection in abdominal CT.
Eichler M; May M; Wiesmueller M; Saake M; Heiss R; Uder M; Wuest W
Eur J Radiol; 2020 May; 126():108913. PubMed ID: 32135408
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and Safety of liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial.
Kim BK; Kim DY; Byun HK; Choi HJ; Beom SH; Lee HW; Kim SU; Park JY; Ahn SH; Seong J; Han KH
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):106-115. PubMed ID: 32084526
[TBL] [Abstract] [Full Text] [Related]
13. liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.
Wang H; Qian YW; Wu MC; Cong WM
J Gastrointest Surg; 2020 Dec; 24(12):2737-2747. PubMed ID: 31768830
[TBL] [Abstract] [Full Text] [Related]
14. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract] [Full Text] [Related]
15. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract] [Full Text] [Related]
16. Experience with Sorafenib in 3 Hospitals in Sao Paulo.
Camargo-Pinheiro-Alves R; Viera-Alves DE; Malzyner A; Gampel O; Almeida-Costa TF; Guz B; Poletti P
Ann Hepatol; 2019; 18(1):172-176. PubMed ID: 31113587
[TBL] [Abstract] [Full Text] [Related]
17. A Novel Noninvasive Program for staging liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
[TBL] [Abstract] [Full Text] [Related]
18. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
[TBL] [Abstract] [Full Text] [Related]
19. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract] [Full Text] [Related]
20. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic liver cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract] [Full Text] [Related]
[Next]
